expert perspectives in the management of triple-negative breast cancer with sara tolaney, md, mph
Published 1 year ago • 141 plays • Length 13:10Download video MP4
Download video MP3
Similar videos
-
1:32
dr tolaney on data with checkpoint inhibitor combinations in metastatic tnbc
-
28:21
expanding role of trop2-directed adcs in mbc management — sara m tolaney, md, mph
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
0:41
the importance of brca-1 testing in triple negative breast cancer
-
13:38
near complete remission in stage 4 triple negative breast cancer | #integrativeoncology | aohc
-
5:01
keynote-522: final os findings of pembrolizumab and chemotherapy in tnbc
-
55:29
let’s talk about it: triple-negative breast cancer - cutting-edge research on tnbc
-
3:26
dr. sara tolaney on eribulin plus pembrolizumab for metastatic triple-negative breast cancer
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
21:36
treatment planning for triple negative breast cancer | 2022 evolution conference
-
3:06
dr. sara tolaney on adjuvant cisplatin and radiation for triple-negative breast cancer
-
1:55
sara m. tolaney, md, mph, shares outcomes from the impassion130 study in tnbc
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
1:09
sara m. tolaney on neoadjuvant treatment considerations for triple-negative breast cancer
-
1:19
dr. sara m. tolaney on neoadjuvant treatment considerations for tnbc
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
1:41
dana-farber cancer institute | sara tolaney, md, mph, at sabcs 2020
-
1:13
dr. tolaney discusses patient selection for platinum-based therapy in tnbc
-
1:29
takeaways on the management of early-stage tnbc
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc
-
2:19
treatment optimization trials in breast cancer